Parramatta Eels Won't Extend Josh Addo-Carr Beyond 2027 as Drug Test Matter Cleared

Club Cuts Ties Despite Clearance

Josh Addo-Carr has been told by Parramatta Eels he can look for another club, with the Canberra Times reporting on November 12 that the club confirmed it would not offer him a contract extension beyond 2027. The decision came after the NRL integrity unit cleared the 31-year-old winger following a failed roadside drug test in September, with a subsequent B sample returning negative.

“The Parramatta Eels would like to provide an update regarding Josh Addo-Carr following a driving incident in September,” an Eels statement read. After reviewing all relevant information, including the negative result of the B sample, the club has cleared Josh in relation to the issues raised following the incident.

The Canberra Times

The club made it clear to Addo-Carr's management he won't be offered a new deal after 2027, effectively ending his tenure despite his strong performance for Parramatta. Addo-Carr, who scored 27 tries from 45 appearances after joining the Eels, now faces an uncertain NRL future as he seeks a new club.

Drug Test Drama and Redemption

The saga began in September when Addo-Carr allegedly returned a positive reading to a random roadside drug test in Newtown, five days after scoring a try in Parramatta's 24-22 final round loss to the Dragons. He reportedly checked himself into a rehabilitation clinic on the Central Coast days later. However, a B sample taken at the time of the roadside test later returned a negative result, and his case was dropped by NSW police.

“The NRL has also confirmed it will not be taking any further action, and the club now considers the matter closed,” the Eels statement continued.

This isn't Addo-Carr's first brush with drug testing issues. He was previously sacked by Canterbury-Bankstown at the end of 2024 with his contract torn up with a year to go after testing positive to cocaine during a roadside drug test conducted by police. That incident cost him a chance to be considered for Kangaroos World Cup selection and resulted in the loss of approximately $400,000 worth of personal sponsorships.

Mutual Agreement and Path Forward

Following discussions with club officials including coach Jason Ryles, Addo-Carr and the Eels reached a mutual agreement that it was in his best interests to immediately explore opportunities elsewhere. The club will continue to support him as he considers his next opportunity, but won't stand in his way if he secures a new contract with a rival club.

“Following these discussions, Josh and the club have mutually agreed that it is in his best interests to immediately explore opportunities elsewhere to give Josh the best opportunity to secure his future,” the statement read.

Addo-Carr has the option of seeing out the final year of his Eels deal in 2027, but with the club planning for life after him, the writing appears to be on the wall for his Parramatta tenure.

Club's Future Plans and Market Uncertainty

Parramatta has already been making moves to replace Addo-Carr, with the Sydney Morning Herald reporting the club is close to securing Knights winger James Schiller for 2027, while Jack Bostock and Bradman Best are targets for 2028. The Eels are clearly building for the future, regardless of Addo-Carr's immediate fate.

However, it remains to be seen what appetite there is on the open market for Addo-Carr. While he has scored 167 tries from 224 NRL games and could add to that tally when the Eels play their 2027 season-opening game against the Titans in Las Vegas' Allegiant Stadium, his history of drug-related incidents may deter potential suitors. The club could find itself hamstrung by salary cap constraints if it cannot find a new home for Addo-Carr during the off-season.

If no alternative home for him can be found, the flying winger would otherwise play out his deal at the Eels next season, but with the club's public stance that he won't be re-signed, his future appears to be elsewhere.

Attention Mechanism and Trend Significance

This story is trending across Australian sports media because it represents a dramatic reversal of fortune for one of the NRL's most dynamic players. The attention stems from the intersection of three powerful elements: a high-profile player's career in limbo, the resolution of a major disciplinary matter, and the timing of a club's strategic roster decision.

The initial failed drug test created immediate uncertainty, but the B sample's negative result provided a pathway back to football. Yet Parramatta's decision not to extend his contract transforms what could have been a redemption story into a career-defining moment of market forces. The club's choice reflects not just on Addo-Carr's personal circumstances, but on how teams evaluate risk, loyalty, and future potential when dealing with players who have demonstrated both extraordinary talent and significant controversy.

The Las Vegas angle adds another layer of intrigue—the 2027 season opener represents a tangible milestone that could serve as Addo-Carr's final NRL game for the Eels or his first with a new club. This creates immediate narrative tension for fans and fantasy players alike, driving sustained interest in his next move.